Literature DB >> 15985584

Relative elevation in baseline leukocyte count predicts first cerebral infarction.

M S V Elkind1, R R Sciacca, B Boden-Albala, T Rundek, M C Paik, R L Sacco.   

Abstract

BACKGROUND: Atherosclerosis is an inflammatory disease, and leukocyte levels are associated with future risk of ischemic cardiac disease.
OBJECTIVE: To investigate the hypothesis that relative elevations in leukocyte count in a stroke-free population predict future ischemic stroke (IS).
METHODS: A population-based prospective cohort study was performed in a multiethnic urban population. Stroke-free community participants were identified by random-digit dialing. Leukocyte levels were measured at enrollment, and participants were followed annually for IS, myocardial infarction (MI), and cause-specific mortality. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% CIs for IS, MI, and vascular death after adjustment for medical, behavioral, and socioeconomic factors.
RESULTS: Among 3,103 stroke-free community participants (mean age 69.2 +/- 10.3 years) with baseline leukocyte levels measured, median follow-up was 5.2 years. After adjusting for stroke risk factors, each SD in leukocyte count (1.8 x 10(9) cells/L) was associated with an increased risk of IS (HR 1.22, 95% CI 1.05 to 1.42), and IS, MI, or vascular death (HR 1.13, 95% CI 1.02 to 1.26). Compared with those in the lowest quartile of leukocyte count, those in the highest had an increased risk of IS (adjusted HR 1.75, 95% CI 1.08 to 2.82). The effect on atherosclerotic and cardioembolic stroke was greater than in other stroke subtypes.
CONCLUSION: Relative elevations in leukocyte count are independently associated with an increased risk of future ischemic stroke and other cardiovascular events.

Entities:  

Mesh:

Year:  2005        PMID: 15985584     DOI: 10.1212/01.WNL.0000165989.12122.49

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

Review 1.  Blood biologic markers of stroke: improved management, reduced cost?

Authors:  Alison E Baird
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

2.  The 2006 William Feinberg lecture: shifting the paradigm from stroke to global vascular risk estimation.

Authors:  Ralph L Sacco
Journal:  Stroke       Date:  2007-05-10       Impact factor: 7.914

Review 3.  Inflammatory markers and stroke.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

4.  The relationship between hematological parameters and prognosis of children with acute ischemic stroke.

Authors:  Ebru Yilmaz; Ayse Bayram Kacar; Adil Bozpolat; Gokmen Zararsiz; Burcu S Gorkem; Musa Karakukcu; Turkan Patiroglu; Hakan Gumus; Mehmet Akif Ozdemir; Alper Ozcan; Huseyin Per; Ekrem Unal
Journal:  Childs Nerv Syst       Date:  2017-12-05       Impact factor: 1.475

5.  White blood cell count and endothelin-1 vasoconstrictor tone in middle-aged and older adults.

Authors:  Kyle J Diehl; Brian R Weil; Jared J Greiner; Brian L Stauffer; Christopher A Desouza
Journal:  Artery Res       Date:  2012-06-01       Impact factor: 0.597

6.  Total and differential white blood cell counts in late life predict 8-year incident stroke: the Honolulu Heart Program.

Authors:  Ji Young Huh; George Webster Ross; Randi Chen; Robert D Abbott; Christina Bell; Bradley Willcox; Lenore Launer; Helen Petrovitch; Brock Kaya; Kamal Masaki
Journal:  J Am Geriatr Soc       Date:  2015-03-04       Impact factor: 5.562

7.  Infectious burden and risk of stroke: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Pankajavalli Ramakrishnan; Yeseon P Moon; Bernadette Boden-Albala; Khin M Liu; Steve L Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Arch Neurol       Date:  2009-11-09

8.  Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.

Authors:  Mira Katan; Yeseon P Moon; Myunghee C Paik; Beat Mueller; Andreas Huber; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-05-19       Impact factor: 7.914

9.  Infectious burden and carotid plaque thickness: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Jorge M Luna; Yeseon Park Moon; Bernadette Boden-Albala; Khin M Liu; Steven Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Stroke       Date:  2010-01-14       Impact factor: 7.914

10.  Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.

Authors:  Mitchell S V Elkind; Wanling Tai; Kristen Coates; Myunghee C Paik; Ralph L Sacco
Journal:  Cerebrovasc Dis       Date:  2008-11-15       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.